These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7730149)

  • 1. Correlation of gene-specific damage with cisplatin between human adenocarcinoma cells and peripheral blood mononuclear cells analyzed by polymerase chain reaction-stop assay.
    Oshita F; Arioka H; Heike Y; Shiraishi J; Saijo N
    Jpn J Cancer Res; 1995 Feb; 86(2):233-8. PubMed ID: 7730149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene-specific damage produced by topoisomerase inhibitors in human lung cancer cells and peripheral mononuclear cells as assayed by polymerase chain reaction-stop assay.
    Oshita F; Yamada K; Nomura I; Noda K
    Anticancer Res; 1998; 18(5A):3389-93. PubMed ID: 9858913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of therapeutic outcome in non-small cell lung cancer and DNA damage assayed by polymerase chain reaction in leukocytes damaged in vitro.
    Oshita F; Yamamoto N; Fukuda M; Ohe Y; Tamura T; Eguchi K; Shinkai T; Saijo N
    Cancer Res; 1995 Jun; 55(11):2334-7. PubMed ID: 7757984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid polymerase chain reaction assay to detect variation in the extent of gene-specific damage between cisplatin- or VP-16-resistant and sensitive lung cancer cell lines.
    Oshita F; Saijo N
    Jpn J Cancer Res; 1994 Jul; 85(7):669-73. PubMed ID: 8071107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene-specific damage produced by cisplatin, ormaplatin and UV light in human cells as assayed by the polymerase chain reaction.
    Oshita F; Eastman A
    Oncol Res; 1993; 5(3):111-8. PubMed ID: 8260747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A polymerase chain reaction-based method to detect cisplatin adducts in specific genes.
    Jennerwein MM; Eastman A
    Nucleic Acids Res; 1991 Nov; 19(22):6209-14. PubMed ID: 1956780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulated HMGB1 in the pleural effusion of non-small cell lung cancer (NSCLC) patients reduces the chemosensitivity of NSCLC cells.
    Ma Y; Kang S; Wu X; Han B; Jin Z; Guo Z
    Tumori; 2018 Oct; 104(5):338-343. PubMed ID: 28885675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of DNA damage in transcriptionally active genes by RT-PCR and assessment of repair of cisplatin-induced damage in the glutathione S-transferase-pi gene in human glioblastoma cells.
    Brandt TY; Ali-Osman F
    Toxicol Appl Pharmacol; 1997 Mar; 143(1):22-9. PubMed ID: 9073588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cisplatin-DNA adduct determination in the hepatic albumin gene as compared to whole genomic DNA.
    Zhang Z; Poirier MC
    Chem Res Toxicol; 1997 Sep; 10(9):971-7. PubMed ID: 9305578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of a PCR-based assay for the selection of patients more likely to benefit from therapeutic treatment with alkylating drugs.
    Stefanou DT; Episkopou H; Kyrtopoulos SA; Bamias A; Gkotzamanidou M; Bamia C; Liakou C; Bekyrou M; Sfikakis PP; Dimopoulos MA; Souliotis VL
    Br J Clin Pharmacol; 2012 Nov; 74(5):842-53. PubMed ID: 22432918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymerase chain reaction analysis of cisplatin-induced mitochondrial DNA damage in human ovarian carcinoma cells.
    Daoud SS; Clements MK; Small CL
    Anticancer Drugs; 1995 Jun; 6(3):405-12. PubMed ID: 7670138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Procoagulant activity of purified protein derivative-stimulated pleural effusion mononuclear cells in tuberculous pleurisy.
    Hoheisel G; Roth M; Chan CH; Tsakiris DA; Fehr B; Ruff PW; Perruchoud AP
    Respiration; 1997; 64(2):152-8. PubMed ID: 9097351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of DNA mismatch repair in acquired resistance to cisplatin.
    Aebi S; Kurdi-Haidar B; Gordon R; Cenni B; Zheng H; Fink D; Christen RD; Boland CR; Koi M; Fishel R; Howell SB
    Cancer Res; 1996 Jul; 56(13):3087-90. PubMed ID: 8674066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear and mitochondrial distribution of organoamidoplatinum(II) lesions in cisplatin-sensitive and -resistant adenocarcinoma cells.
    Talarico T; Cullinane CM; Gray PJ; Webster LK; Deacon GB; Phillips DR
    Anticancer Drug Des; 2001; 16(2-3):135-41. PubMed ID: 11962511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human lung adenocarcinoma cell cultures derived from malignant pleural effusions as model system to predict patients chemosensitivity.
    Roscilli G; De Vitis C; Ferrara FF; Noto A; Cherubini E; Ricci A; Mariotta S; Giarnieri E; Giovagnoli MR; Torrisi MR; Bergantino F; Costantini S; Fenizia F; Lambiase M; Aurisicchio L; Normanno N; Ciliberto G; Mancini R
    J Transl Med; 2016 Feb; 14():61. PubMed ID: 26928703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of DNA damage and repair in murine leukemia L1210 cells using a quantitative polymerase chain reaction assay.
    Kalinowski DP; Illenye S; Van Houten B
    Nucleic Acids Res; 1992 Jul; 20(13):3485-94. PubMed ID: 1630919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platinum-containing compound platinum pyrithione is stronger and safer than cisplatin in cancer therapy.
    Zhao C; Chen X; Zang D; Lan X; Liao S; Yang C; Zhang P; Wu J; Li X; Liu N; Liao Y; Huang H; Shi X; Jiang L; Liu X; He Z; Wang X; Liu J
    Biochem Pharmacol; 2016 Sep; 116():22-38. PubMed ID: 27381943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cisplatin-induced apoptosis and p53 gene status in a cisplatin-resistant human ovarian carcinoma cell line.
    Fajac A; Da Silva J; Ahomadegbe JC; Rateau JG; Bernaudin JF; Riou G; Bénard J
    Int J Cancer; 1996 Sep; 68(1):67-74. PubMed ID: 8895543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of down-regulation of survivin gene on apoptosis and cisplatin resistance in cisplatin resistant human lung adenocarcinoma A549/CDDP cells].
    Zhang MC; Hu CP; Chen Q
    Zhonghua Zhong Liu Za Zhi; 2006 Jun; 28(6):408-12. PubMed ID: 17152483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA damage by anti-cancer agents resolved at the nucleotide level of a single copy gene: evidence for a novel binding site for cisplatin in cells.
    Grimaldi KA; McAdam SR; Souhami RL; Hartley JA
    Nucleic Acids Res; 1994 Jun; 22(12):2311-7. PubMed ID: 8036159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.